Uruganda ruhendutse 2-

Amagambo yihuse kandi asumba ayandi, abajyanama bamenyeshejwe kugirango bagufashe guhitamo igisubizo kiboneye gikwiranye nibyo ukeneye byose, igihe gito, ibisekuruza byujuje ubuziranenge hamwe nibicuruzwa bidasanzwe na serivisi zo kwishyura no kohereza ibicuruzwa ku ruganda ruhendutse 2- [(6-Chloro-3 , 4-dihydro-3-Methyl-2, 4-dioxo-1 (2H) -pyriMidinyl) Methyl] - CAS 865758-96-9 hamwe nigiciro cyiza, Niba ushaka ubuziranenge bwiza, gutanga vuba, byiza nyuma ya serivisi kandi utanga ibiciro byiza mubushinwa kubucuruzi bwigihe kirekire, tuzakubera amahitamo meza.
Amagambo yihuse kandi asumba ayandi, abajyanama bamenyeshejwe kugirango bagufashe guhitamo igisubizo kiboneye gikwiranye nibyo ukeneye byose, igihe gito cyibisekuru, igisubizo cyiza cyiza hamwe nibicuruzwa bidasanzwe na serivisi zo kwishyura no kohereza ibintuUbushinwa 865758-96-9 na 2- [(6-Chloro-3 4-dihydro-3-Methyl-, Twebwe igisubizo twanyuze mubyemezo byigihugu byubuhanga kandi twakiriwe neza mubikorwa byingenzi byacu.Itsinda ryacu ryinzobere mu buhanga rizaba ryiteguye kugukorera inama no gutanga ibitekerezo.Twashoboye kandi kuguha nta byitegererezo byigiciro kugirango uhuze ibyo ukeneye.Imbaraga nziza zishobora gutangwa kugirango tuguhe serivisi nziza nibisubizo.Kubantu bose batekereza kubucuruzi nibisubizo byacu, nyamuneka tuvugane utwoherereza imeri cyangwa utumenyeshe ako kanya.Nuburyo bwo kumenya ibicuruzwa byacu nibisubizo hamwe na entreprise.byinshi cyane, uzashobora kuza muruganda rwacu kugirango ubimenye.Tuzahora twakira abashyitsi baturutse hirya no hino ku isi.o kubaka imishinga.kwishima hamwe natwe.Ugomba rwose kumva ufite umudendezo rwose kugirango utumenyeshe kubucuruzi buciriritse kandi twizera ko tuzasangira ubunararibonye bwubucuruzi bwo hejuru nabacuruzi bacu bose.

2 - (((-6

Trogliptin succinate ni dipeptidyl peptidase Ⅳ (DPP - Ⅳ) inhibitor yakozwe na Takeda (Takeda Pharmaceutical Co., Ltd.) mu Buyapani.Irashobora guhitamo no gukomeza kubuza DPP - Ⅳ no kugenzura urwego glucose yamaraso.Igeragezwa rya Clinical ryerekana ko imiti ifite umutekano mwiza kandi neza.Rimwe mu cyumweru birashobora kugenzura neza glucose yamaraso no kunoza imiti abarwayi.Muri Gicurasi, 2015, uyu muti wemejwe n’Ubuyapani PMDA gushyirwa ku rutonde rwo kuvura diyabete.

Amagambo yihuse kandi asumba ayandi, abajyanama bamenyeshejwe kugirango bagufashe guhitamo igisubizo kiboneye gikwiranye nibyo ukeneye byose, igihe gito, ibisekuruza byujuje ubuziranenge hamwe nibicuruzwa bidasanzwe na serivisi zo kwishyura no kohereza ibicuruzwa ku ruganda ruhendutse 2- [(6-Chloro-3 , 4-dihydro-3-Methyl-2, 4-dioxo-1 (2H) -pyriMidinyl) Methyl] - CAS 865758-96-9 hamwe nigiciro cyiza, Niba ushaka ubuziranenge bwiza, gutanga vuba, byiza nyuma ya serivisi kandi utanga ibiciro byiza mubushinwa kubucuruzi bwigihe kirekire, tuzakubera amahitamo meza.
Uruganda ruhendutseUbushinwa 865758-96-9 na 2- [(6-Chloro-3 4-dihydro-3-Methyl-, Twebwe igisubizo twanyuze mubyemezo byigihugu byubuhanga kandi twakiriwe neza mubikorwa byingenzi byacu.Itsinda ryacu ryinzobere mu buhanga rizaba ryiteguye kugukorera inama no gutanga ibitekerezo.Twashoboye kandi kuguha nta byitegererezo byigiciro kugirango uhuze ibyo ukeneye.Imbaraga nziza zishobora gutangwa kugirango tuguhe serivisi nziza nibisubizo.Kubantu bose batekereza kubucuruzi nibisubizo byacu, nyamuneka tuvugane utwoherereza imeri cyangwa utumenyeshe ako kanya.Nuburyo bwo kumenya ibicuruzwa byacu nibisubizo hamwe na entreprise.byinshi cyane, uzashobora kuza muruganda rwacu kugirango ubimenye.Tuzahora twakira abashyitsi baturutse hirya no hino ku isi.o kubaka imishinga.kwishima hamwe natwe.Ugomba rwose kumva ufite umudendezo rwose kugirango utumenyeshe kubucuruzi buciriritse kandi twizera ko tuzasangira ubunararibonye bwubucuruzi bwo hejuru nabacuruzi bacu bose.